We are international
Donate
TEXT SIZE   


Past Meetings
10.18.01

WAM 2000: Waldenstroms, Amyloidosis & Myeloma
September 22-24, 2000
Phoenix, Arizona

Program Overview:
This educational activity provided a topical overview of diagnostic, management and research efforts focused on multiple myeloma, Waldenstroms and amyloidosis. Data from recent studies was discussed. The importance of patient education and lifestyle management was also addressed.

Target Audience:
This program was designed to meet the educational needs of hematologists and oncologists who care for patients with multiple myeloma, Waldenstroms and amyloidosis.

Program Objectives:

At the conclusion of the conference, participants should be able to do the following:

  • Discuss new diagnostic and prognostic factor technologies that may improve the baseline evaluation of patients with multiple myeloma, Waldenstroms and amyloidosis.
  • Summarize the latest information about front-line treatment for multiple myeloma, Waldenstroms and amyloidosis.
  • Discuss alternative approaches to treatment for patients who fail to respond to standard therapy.
    Review current supportive care measures for bone care, anemia, pain management, neuropathy and kidney dysfunction to allow maximum opportunity for improvement in quality of life for patients with multiple myeloma, Waldenstroms and amyloidosis.


 related articles